Ophthalmology
Some viruses are promising vectors for intraocular gene delivery
Published in Gene Therapy Weekly, July 24th, 2003
"There has been significant progress in the last few years in demonstrating the utility of recombinant viral vectors in treating a variety of ocular diseases. The field has moved beyond 'proof-of-principle' and, in fact, has entered the phase where some of these vectors/paradigms are being or soon will be evaluated in human clinical trials.
"For this reason and also, to increase the understanding of immunological effects of transgenes/viral vectors on the eye, it is important to summarize what is known about these effects," according to J. Bennett, University of Pennsylvania, Scheie...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-07-24)
More Articles from Gene Therapy Weekly
- Metabolic Disease
Adeno-associated virus type 1 corrects storage lesions in enzyme-deficient mice - Cardiac Transplantation
Feline immunodeficiency virus-mediated gene transfer prolongs graft survival - Stem Cell Research
Human foreskin feeders can nourish human embryonic stem cells in culture - Vector Development
A novel method discerns the quality of transgene expression in vector stocks - Cellular Therapy
$12 million gift to Columbia propels diabetes treatment into new era - Diabetes Therapy
Antisense oligonucleotide to PTP1B reduces diabetes factors in obese mice - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
